IDT and VH Bio have also announced an agreement to work together to grow IDT’s oligonucleotide business in the UK. The two companies will combine efforts to introduce IDT’s market-leading products to scientists throughout the country.
Dr. Joseph A. Walder, IDT’s founder and CEO commented, “From its earliest beginnings, IDT’s mission has been to provide scientists with the very best in synthetic oligonucleotides. IDT has always understood that to mean peerless quality, leading technology, the broadest scope, and truly collaborative customer service – all at the lowest cost possible to the researcher. We are eager to serve VH Bio’s customers and are honored that VH Bio has chosen to entrust their customers to us.”
Andrew Hewitt, VH Bio’s Managing Director, remarked that “IDT has clearly established itself as the market leader in oligonucleotide synthesis, innovation, and service. We’re looking forward to sharing with our colleagues here in the UK what we’ve come to know about IDT’s unmatched ability to support researchers in both academia and industry. This agreement will also facilitate the continuing expansion of the molecular biology product lines we presently offer.”
IDT officially opened its European synthesis facility in Leuven in September 2008, and now has branches in both the UK and Germany. For more information on IDT’s full product range, please visit their website at www.idtdna.com.
Contact:
Integrated DNA Technologies Lynette Brown Advertising and Product Manager t: +1 319-665-7208 e: lbrown@idtdna.com or Alto Marketing Limited Neil Ravenhill Scientific Communications Manager t: +44 (0)1489 557672 e:neilr@alto-marketing.com
